DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vidaza (Azacitidine Subcutaneous) - Current Clinical Trials

 
 



Vidaza Related Clinical Trials

Azacitidine and CAPOX in Metastatic Colorectal Cancer [Active, not recruiting]

An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia [Recruiting]

A Study of Nivolumab (BMS-936558) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia [Recruiting]

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) [Recruiting]

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) [Active, not recruiting]

5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia [Terminated]

Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer [Terminated]

Phase I 5-Azacytidine Plus VPA Plus ATRA [Completed]

Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) [Active, not recruiting]

Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation [Recruiting]

Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS) [Not yet recruiting]

The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q). [Recruiting]

A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies [Completed]

5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) [Active, not recruiting]

Phase II 5-Azacytidine Plus VPA Plus ATRA [Completed]

Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function [Completed]

Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) [Terminated]

Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) [Not yet recruiting]

Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes [Withdrawn]

Nivolumab and Ipilimumab With 5-azacitidine in Patients With Myelodysplastic Syndromes (MDS) [Not yet recruiting]

Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer [Completed]

Randomized Allogeneic Azacitidine Study [Recruiting]

A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML [Completed]

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation. [Recruiting]

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML) [Completed]

Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Active, not recruiting]

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma [Completed]

5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome [Active, not recruiting]

Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Terminated]

Azacytidine and Valproic Acid in Patients With Advanced Cancers [Completed]

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS [Recruiting]

Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients [Completed]

Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk [Recruiting]

Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS) [Active, not recruiting]

VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome [Recruiting]

Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer [Completed]

Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome [Completed]

PKC412 and 5-Azacytidine [Completed]

Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia [Recruiting]

Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS [Recruiting]

A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia [Active, not recruiting]

A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma [Recruiting]

Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia [Active, not recruiting]

Oral Rigosertib in Combination With Azacitidine [Recruiting]

Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide [Terminated]

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes [Completed]

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes [Terminated]

Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation [Completed]

A Study of 5-Azacitidine (VidazaŽ) in Patients With Chronic Myelomonocytic Leukemia [Completed]

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS) [Active, not recruiting]

Combination Study of Cytarabine and Tosedostat in Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS) [Recruiting]

A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer [Recruiting]

Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes [Recruiting]

Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia [Recruiting]

Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Terminated]

A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes [Terminated]

5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs) [Completed]

Inhaled Azacitidine in Patients With Advanced Non-small Cell Lung Cancer [Recruiting]

Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) [Completed]

Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma [Active, not recruiting]

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Active, not recruiting]

Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy [Active, not recruiting]

AVIDA The VidazaŽ (Azacitidine) Patient Registry [Completed]

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine [Active, not recruiting]

Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant [Completed]

A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients [Recruiting]

Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) [Completed]

Ph II Study of Azacitidine in Myelofibrosis [Completed]

Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes [Active, not recruiting]

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients [Active, not recruiting]

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) [Completed]

In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease [Completed]

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia [Active, not recruiting]

Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients [Completed]

Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes [Recruiting]

Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Recruiting]

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant [Completed]

Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL [Terminated]

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) [Completed]

VIDAZAŽ in Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia [Recruiting]

Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer [Active, not recruiting]

Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy [Recruiting]

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma [Active, not recruiting]

5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome [Recruiting]

Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZAŽ, After Approval of Marketing Authorization for New Drug in Korea [Recruiting]

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia [Active, not recruiting]

Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer [Terminated]

Azacytidine Plus FLAG for Relapsed or Refractory AML [Recruiting]

Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS [Not yet recruiting]

Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer [Active, not recruiting]

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery [Terminated]

AC220 With 5-Aza or Low Dose Cytarabine [Recruiting]

A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015